Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. - Gralla,R.J.; Lichinitser,M.; Van der Vegt,S. (Ann Oncol, 2003)